HK1071567A1 - Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for thetreatment of obesity - Google Patents
Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for thetreatment of obesityInfo
- Publication number
- HK1071567A1 HK1071567A1 HK05104387A HK05104387A HK1071567A1 HK 1071567 A1 HK1071567 A1 HK 1071567A1 HK 05104387 A HK05104387 A HK 05104387A HK 05104387 A HK05104387 A HK 05104387A HK 1071567 A1 HK1071567 A1 HK 1071567A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- spirosubstituted
- thetreatment
- piperidines
- obesity
- receptor antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39181302P | 2002-06-27 | 2002-06-27 | |
PCT/US2003/020088 WO2004002987A1 (en) | 2002-06-27 | 2003-06-26 | Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1071567A1 true HK1071567A1 (en) | 2005-07-22 |
Family
ID=30000757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05104387A HK1071567A1 (en) | 2002-06-27 | 2005-05-25 | Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for thetreatment of obesity |
Country Status (15)
Country | Link |
---|---|
US (1) | US7109207B2 (zh) |
EP (1) | EP1532147B1 (zh) |
JP (1) | JP4522853B2 (zh) |
CN (1) | CN100374440C (zh) |
AR (1) | AR040344A1 (zh) |
AT (1) | ATE334983T1 (zh) |
AU (1) | AU2003258957A1 (zh) |
CA (1) | CA2490531C (zh) |
DE (1) | DE60307289T2 (zh) |
ES (1) | ES2266861T3 (zh) |
HK (1) | HK1071567A1 (zh) |
MX (1) | MXPA05000185A (zh) |
PE (1) | PE20040749A1 (zh) |
TW (1) | TW200401777A (zh) |
WO (1) | WO2004002987A1 (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2468015A1 (en) | 2001-11-27 | 2003-06-05 | Merck & Co., Inc. | 2-aminoquinoline compounds |
AU2004209505B2 (en) | 2003-02-10 | 2009-07-23 | Banyu Pharmaceutical Co., Ltd. | Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
WO2004078745A1 (en) * | 2003-02-28 | 2004-09-16 | Schering Corporation | Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
EP1732928A2 (en) | 2004-03-29 | 2006-12-20 | Pfizer, Inc. | Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists |
TW200630337A (en) * | 2004-10-14 | 2006-09-01 | Euro Celtique Sa | Piperidinyl compounds and the use thereof |
JPWO2006104136A1 (ja) * | 2005-03-29 | 2008-09-11 | 萬有製薬株式会社 | 非アルコール性脂肪性肝疾患の治療剤、及び非アルコール性脂肪性肝疾患の治療又は予防のための薬剤の候補化合物のスクリーニング方法 |
WO2007110449A1 (en) * | 2006-03-29 | 2007-10-04 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use |
US8937181B2 (en) * | 2006-04-13 | 2015-01-20 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
US8791264B2 (en) * | 2006-04-13 | 2014-07-29 | Purdue Pharma L.P. | Benzenesulfonamide compounds and their use as blockers of calcium channels |
CA2664358A1 (en) * | 2006-09-28 | 2008-04-03 | Banyu Pharmaceutical Co., Ltd. | Diarylketimine derivative |
US8399486B2 (en) * | 2007-04-09 | 2013-03-19 | Purdue Pharma L.P. | Benzenesulfonyl compounds and the use thereof |
US8765736B2 (en) * | 2007-09-28 | 2014-07-01 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
US9090084B2 (en) | 2010-05-21 | 2015-07-28 | Hewlett-Packard Development Company, L.P. | Fluid ejection device including recirculation system |
US9963739B2 (en) | 2010-05-21 | 2018-05-08 | Hewlett-Packard Development Company, L.P. | Polymerase chain reaction systems |
JP2017535545A (ja) * | 2014-11-21 | 2017-11-30 | ラボラトリオス・デル・デエレ・エステベ・エセ・ア | 疼痛に対する多様な活性を有するスピロ−イソキノリン−1,4’−ピペリジン化合物 |
CN107312056B (zh) * | 2017-08-24 | 2019-10-25 | 广西师范学院 | 2-(3’-羟基-17’-孕甾烷基)-5-氟苯并咪唑的合成方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5908830A (en) * | 1996-10-31 | 1999-06-01 | Merck & Co., Inc. | Combination therapy for the treatment of diabetes and obesity |
TWI279402B (en) * | 1999-08-20 | 2007-04-21 | Banyu Pharma Co Ltd | Spiro compounds having NPY antagonistic activities and agents containing the same |
EP1206262A4 (en) * | 1999-08-26 | 2003-01-02 | Bristol Myers Squibb Co | Y NEUROPEPTID ANTAGONISTS: SPIROISOQUINOLINONE DERIVATIVES |
JP2003527444A (ja) * | 2000-03-23 | 2003-09-16 | メルク エンド カムパニー インコーポレーテッド | メラノコルチン受容体アゴニストとして作用するスピロピペリジン誘導体 |
EP1299362A4 (en) * | 2000-07-05 | 2004-11-03 | Synaptic Pharma Corp | SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE |
-
2003
- 2003-06-26 JP JP2004517838A patent/JP4522853B2/ja not_active Expired - Fee Related
- 2003-06-26 CN CNB038151936A patent/CN100374440C/zh not_active Expired - Fee Related
- 2003-06-26 US US10/607,051 patent/US7109207B2/en not_active Expired - Fee Related
- 2003-06-26 AU AU2003258957A patent/AU2003258957A1/en not_active Abandoned
- 2003-06-26 TW TW092117445A patent/TW200401777A/zh unknown
- 2003-06-26 AT AT03762050T patent/ATE334983T1/de not_active IP Right Cessation
- 2003-06-26 CA CA2490531A patent/CA2490531C/en not_active Expired - Fee Related
- 2003-06-26 AR ARP030102294A patent/AR040344A1/es unknown
- 2003-06-26 PE PE2003000647A patent/PE20040749A1/es not_active Application Discontinuation
- 2003-06-26 EP EP03762050A patent/EP1532147B1/en not_active Expired - Lifetime
- 2003-06-26 DE DE60307289T patent/DE60307289T2/de not_active Expired - Lifetime
- 2003-06-26 WO PCT/US2003/020088 patent/WO2004002987A1/en active IP Right Grant
- 2003-06-26 ES ES03762050T patent/ES2266861T3/es not_active Expired - Lifetime
- 2003-06-26 MX MXPA05000185A patent/MXPA05000185A/es active IP Right Grant
-
2005
- 2005-05-25 HK HK05104387A patent/HK1071567A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP4522853B2 (ja) | 2010-08-11 |
TW200401777A (en) | 2004-02-01 |
US20040024002A1 (en) | 2004-02-05 |
MXPA05000185A (es) | 2005-04-08 |
CA2490531A1 (en) | 2004-01-08 |
DE60307289D1 (de) | 2006-09-14 |
CN1665812A (zh) | 2005-09-07 |
PE20040749A1 (es) | 2004-10-23 |
JP2005535641A (ja) | 2005-11-24 |
WO2004002987A1 (en) | 2004-01-08 |
EP1532147A1 (en) | 2005-05-25 |
ATE334983T1 (de) | 2006-08-15 |
ES2266861T3 (es) | 2007-03-01 |
CA2490531C (en) | 2011-03-22 |
EP1532147B1 (en) | 2006-08-02 |
DE60307289T2 (de) | 2007-10-18 |
CN100374440C (zh) | 2008-03-12 |
AU2003258957A1 (en) | 2004-01-19 |
AR040344A1 (es) | 2005-03-30 |
US7109207B2 (en) | 2006-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1071567A1 (en) | Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for thetreatment of obesity | |
AU2003243497A8 (en) | Antagonists of melanin concentrating hormone receptor | |
EP1653960A4 (en) | MELANIN CONCENTRATION HORMONE RECEPTOR ANTAGONIST | |
HK1047580B (zh) | 在糖尿病治療中作為糖皮質激素受體對抗劑的二苯並吡喃 | |
IL190898A0 (en) | Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists | |
AU2003261392A8 (en) | M3muscarinic acetylcholine receptor antagonists | |
AU2003287880A8 (en) | Cyclic quinoline compounds for use in mch receptor related disorders | |
EP1444251A4 (en) | CYCLIC PEPTIDES AS G PROTEIN-COUPLED RECEPTOR ANTAGONISTS | |
HK1107261A1 (en) | Method of wound healing using a2b adenosine receptor antagonists | |
EP1536813A4 (en) | COMPOSITIONS AND METHODS FOR PROTEIN-ACTIVATED RECEPTOR ANTAGONISTS | |
PL378753A1 (pl) | Antagoniści receptora CCR-3 | |
AU2003267088A8 (en) | Chemokine receptor antagonists as therapeutic agents | |
AU2003300904A8 (en) | Antagonists for human prolactin | |
AU2003280675A1 (en) | SELECTIVE HUMAN Beta3 ADRENALIN RECEPTOR AGONIST AGENT | |
IL180098A0 (en) | Methods for predicting therapeutic pesponse to agents acting on the growth hormone receptor | |
HK1082796A1 (zh) | 人p2y15g蛋白偶聯受體的調控 | |
IL180107A0 (en) | Lactam tachykinin receptor antagonists | |
HK1085926A1 (en) | Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis | |
AU2003297124A8 (en) | F11 receptor(f11r) antagonists as therapeutic agents | |
AU2003250685A8 (en) | Methods of identifying selective beta-1-adrenergic receptor antagonists | |
AU2003242848A8 (en) | Nuclear hormone receptor ligano-binding domain containing protein | |
TW535558U (en) | Improved structure of device for clamping toilet device | |
AU2003244831A8 (en) | Human nuclear hormone receptor | |
AU2002320824A1 (en) | Regulation of human trace amine receptor ta5 | |
SI1594520T1 (sl) | Uporaba antagonistov bradikinin-B2 receptorja za zdravljenje osteoartroze |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CORR | Corrigendum |
Free format text: CORRECTED DATA OF SECTION 20 TO JOURNAL OF 20050722: [54] SPIROSUBSTITUTED PIPERIDINES AS SELECTIVEMELANIN CONCENTRATING - HORMONE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OBESITY |
|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20100626 |